SAFE, PRIVATE & SECURE
Your iOPharma™ account is password protected and safe from prying eyes. All iOPharma™ plans include SSL security - the same as online banks. Your data is secure.
SUPPORT FOR MULTIPLE LANGUAGES
iOPharma™ will be translated into Chinese, Spanish, French, German and Portuguese. More languages will be added to this list as time goes on. To find out more about the translations, please contact us at info@io-pharma.com.
FREE REGISTRATION
Whether you’re a buyer or a supplier the iOPharma™ platform will benefit your organisation.
REGISTER NOW
New therapeutic target discovered for Alzheimer's disease
A team of scientists from the University of California, San Diego School of Medicine, the Medical...
Read moreMajor breakthrough in developing new cancer drugs: Capturing leukemic stem cells
The Institute for Research in Immunology and Cancer (IRIC) at the University de Montréal in...
Read moreStatin side-effects minimal, study finds
Pills that lower cholesterol to prevent heart disease carry very low likelihood of adverse affects,...
Read moreOpium poppies to be legalised in Victoria as demand for painkillers soars
Bill to decriminalise the narcotic crop passes parliament, potentially bringing $100m in annual...
Read moreHoney is a new approach to fighting antibiotic resistance
Honey, that delectable condiment for breads and fruits, could be one sweet solution to the serious,...
Read moreNew technology "driving breakthrough opportunities for life science firms"
The new wave of technology is driving breakthrough approaches in life science companies’...
Read moreUniversity defends pharma-funded report from MSF critics
A leading UK university has reacted with bemusement to criticism from Medecins Sans Frontieres...
Read moreBetter funding call for vital drug approval programme
Without the prequalification programme of the World Health Organisation, Africa could have bad...
Read moreInquiry into alleged GlaxoSmithKline bribery in China has led to pay fudge
In the circumstances, GlaxoSmithKline's pay committee faced a tricky problem when determining...
Read moreLife sciences execs turning their backs on social media
Executives in the pharma and biotech industries have had their fill of social media and are "moving...
Read more